Ravi Shankar – Page 526

First National Corporation Reports Record Third Quarter and Year to Date 2026 Financial Performance

Posted on October 23, 2026 by Ravi Shankar

STRASBURG, Va., Oct. 23, 2026 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported consolidated net income of $6.9 million and basic and diluted earnings per common share of $0.76, for the three months ended September 30, 2026. The Company reported consolidated net income of $17.5 million and basic and diluted earnings per common share of $1.94 and $1.93, respectively, for the nine months ended September 30, 2026.

“We are extremely pleased with our record financial performance for the quarter and the year. Organic loan growth continued in the third quarter with strong new loan production in all our markets. The improved net interest margin, excellent asset quality, and expense management drove the financial performance in the third quarter. Our branch optimization process was completed as we closed and consolidated three banking offices and closed our off-site ATMs in the third quarter. In early October we completed the sale of our two North Carolina banking offices and will book a gain in the fourth quarter,” said Scott C. Harvard, President and Chief Executive Officer of First National Corporation.

FINANCIAL HIGHLIGHTS FOR THIRD QUARTER OF 2026

Basic earnings per share of $0.76 per share, compared to $0.62 one year prior, and $0.64 in the previous quarter
Return on average assets of 1.32% compared to 1.09% one year prior, and 1.11% in the previous quarter
Return on average equity of 14.02% compared to 12.43% one year prior, and 12.03% in the previous quarter
Tax equivalent net interest margin⁽¹⁾ of 4.38%, up from 3.84% one year prior, and 4.15% in the previous quarter
Net loan growth of $13.6 million for the quarter, a 3.7% annualized growth rate
Asset quality remained sound with non-performing assets at 0.26% of total assets
Noninterest bearing deposits of $520.1 million, or 28% of deposits, contributed to our low funding cost

FINANCIAL HIGHLIGHTS FOR YEAR TO DATE 2026

Basic earnings per share of $1.94 per share, compared to $1.36 one year prior
Adjusted basic earnings per share ⁽¹⁾ of $1.94 per share, compared to $1.51 one year prior
Return on average assets of 1.15% compared to 0.81% one year prior
Return on average equity of 12.26% compared to 9.47% one year prior
Tax equivalent net interest margin⁽¹⁾of 4.19%, up from 3.85% one year prior
Net loan growth of $67.3 million for the year, a 4.7% growth rate

NET INTEREST INCOME

For the third quarter of 2026, the Company’s net interest margin fully tax equivalent (“FTE”)⁽¹⁾was 4.38%, compared to 4.15% for the second quarter of 2026 and 3.84% in the third quarter of 2025. The Company’s net interest margin (FTE)⁽¹⁾for the third quarter of 2026 includes the impact of acquisition accounting fair value adjustments. Net accretion income related to acquisition accounting was $867 thousand, an 18-basis point incremental increase to the net interest margin for the third quarter ended September 30, 2026. Prior period acquisition accounting resulted in net accretion income of $245 thousand, or a 5-basis point incremental increase to the net interest margin for the quarter ended June 30, 2026, and net accretion income of $43 thousand, with no incremental impact to the net interest margin for the third quarter ended September 30, 2025. The increase in net accretion income as compared to prior quarters was driven by payoffs on purchased loans.

Earning asset yields for the third quarter of 2026 increased 24 basis points to 5.55% compared to the second quarter of 2026. For the third quarter of 2026, net interest income FTE⁽¹⁾was $21.3 million, an increase of $1.2 million from $20.1 million in the second quarter of 2026 due to improved yields and interest income related to acquisition accounting.

The impact of acquisition accretion and amortization is reflected in the following table (dollars in thousands):

	For the Three Months Ended									For the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025			Sept 30, 2026			Sept 30, 2025
Loans	$	958		$	334		$	81		$	1,586		$	1,011
Deposits		(14	)		(14	)		55			(38	)		218
Borrowings		(77	)		(75	)		(93	)		(225	)		(279	)
	$	867		$	245		$	43		$	1,323		$	950

ALLOWANCE AND PROVISION FOR CREDIT LOSSES

The Company recorded no net provision for credit losses in the third quarter of 2026, compared to $426 thousand for the second quarter of 2026. The third quarter provision was comprised of a $64 thousand provision for credit losses on loans, a $79 thousand reduction in provision for credit losses on unfunded commitments, and a $15 thousand provision for credit losses on securities. Net charge-offs totaled $594 thousand in the third quarter of 2026, compared to net charge-offs of $105 thousand in the second quarter of 2026 and net charge-offs of $939 thousand in the third quarter of 2025.

The allowance for credit losses on loans totaled $14.4 million, or 0.96% of total loans on September 30, 2026, compared to $14.9 million, or 1.00% of total loans on June 30, 2026, and $14.4 million, or 1.01% of total loans on September 30, 2025. The allowance for credit losses to total loans decreased from the prior period and prior year due to declines in specific reserves on individually analyzed loans and lower calculated reserves on pooled loans. The allowance for credit losses to non-performing assets coverage was 268% on September 30, 2026, compared to 315% on June 30, 2026, and 253% on September 30, 2025.

NONINTEREST INCOME AND EXPENSE

Noninterest income increased $66 thousand to $4.1 million for the third quarter of 2026 from $4.0 million in the prior quarter. The increase in noninterest income includes increases in wealth management fees, income from bank owned life insurance, and gains on sale of loans held for sale, offset by decreases in brokered mortgage fees, loss on disposals, and other operating income compared to the prior quarter.

Noninterest expense increased $259 thousand to $16.7 million for the third quarter of 2026 from $16.4 million in the prior quarter. The increase in noninterest expense includes increases in employee benefit expense related to our above target net income as well as other real estate owned expense, offset by decreases in marketing expense, legal and professional fees, and other operating expense.

Two banking offices in Roanoke Rapids and Louisburg, North Carolina, including most of the deposit and loan accounts associated with those offices were sold in early October. The company anticipates a one-time gain on the sale of the offices in the fourth quarter of 2026. The Bank consolidated three additional banking offices and discontinued low-volume ATMs at non-branch locations during the third quarter of 2026. The consolidation resulted in other real estate owned expense of $212 thousand in the third quarter. These two closed banking offices are carried as our only other real estate owned and as non-performing assets. The sale and consolidation combined will reduce the number of banking offices from 33 to 28 by year end. The goals of these branch optimization actions are to streamline operations, improve future profitability and allocate resources to faster growing markets.

INCOME TAXES

Income tax expense was $1.7 million for the third quarter of 2026, compared to $1.4 million for the second quarter of 2026. The effective tax rate of 19.7% for the third quarter of 2026 increased slightly from 19.5% in the second quarter of 2026 due to changes in permanent tax differences.

BALANCE SHEET

On September 30, 2026, total assets were $2.075 billion, an increase of $44.1 million or 2.2% from September 30, 2025. Total assets were consistent with the prior quarter with the increase in loan growth offset by decreases in cash and cash equivalents and investment securities, and the increase from the prior year was driven by loan growth funded by decreases in cash and cash equivalents and securities held to maturity.

On September 30, 2026, loans held for investment (“LHFI”) net of allowance totaled $1.486 billion, an increase of $13.4 million or 3.6% annualized from $1.472 billion on June 30, 2026, and an increase of $67.3 million or 4.7% from $1.419 billion on September 30, 2025. Net loan growth in the third quarter and for the year has been driven by increased production from newly hired bankers along with our continued focus on relationship banking.

On September 30, 2026, total investments were $306.8 million, a decrease of $16.0 million or 5.0% from June 30, 2026, and an increase of $1.3 million or 0.4% from September 30, 2025. Available for sale (“AFS”) securities totaled $218.7 million on September 30, 2026, and $227.8 million on June 30, 2026, and $196.5 million on September 30, 2025. The increase compared to the prior year was driven by security purchases exceeding portfolio cashflows and utilization of excess cash. Total net unrealized losses on the AFS securities portfolio were $21.4 million on September 30, 2026, compared to $15.8 million on June 30, 2026, and $15.4 million on September 30, 2025. Held to maturity securities are carried at amortized cost and totaled $82.6 million on September 30, 2026, $89.4 million on June 30, 2026, and $104.6 million on September 30, 2025.

On September 30, 2026, total deposits were $1.829 billion, a decrease of $2.4 million or 0.5% annualized from the prior quarter, and an increase of $19.2 million or 1.1% from September 30, 2025. Average deposit balances for the third quarter declined $17.6 million or 3.8% annualized. Overall, deposit balances were relatively stable in comparison with the prior quarter and the prior year with decreases primarily in interest-bearing demand deposits. There were $25.0 million in other borrowings with the Federal Home Loan Bank on September 30, 2026 and June 30, 2026 and no borrowings on September 30, 2025.

LIQUIDITY

Liquidity sources available to the Bank, including interest-bearing deposits in banks, unpledged securities available for sale, at fair value, and available lines of credit totaled $721.6 million on September 30, 2026, $747.8 million on June 30, 2026, and $676.1 million on September 30, 2025.

The Bank maintains liquidity to fund loan growth and to meet potential demand from deposit customers, including potential volatile deposits. The estimated amount of uninsured customer deposits totaled $575.8 million on September 30, 2026, $573.8 million on June 30, 2026, and $555.0 million on September 30, 2025. Excluding municipal deposits that have collateral pledged, the estimated amount of uninsured customer deposits totaled $483.3 million on September 30, 2026, $466.9 million on June 30, 2026, and $473.4 million on September 30, 2025.

ASSET QUALITY

Non-performing assets (“NPAs”) increased slightly from the prior period and improved from the prior year as previously reserved loans were charged off since the third quarter of 2025. Management classifies NPAs as non-accrual loans and other real estate owned (“OREO”). The Bank had $747 thousand in OREO on September 30, 2026, and no OREO on June 30, 2026 or September 30, 2025. The OREO increase is from the carrying values of two closed banking offices driven by the one-time event of the branch consolidation. Non-accrual loans as a percentage of total loans decreased from prior period and prior year to 0.31% on September 30, 2026. NPAs increased by $647 thousand to $5.4 million on September 30, 2026, compared to $4.7 million on June 30, 2026, but decreased by $318 thousand from $5.7 million on September 30, 2025.

Loans past due over 90 days or more and still accruing interest were $0 on September 30, 2026 and on June 30, 2026, and $388 thousand on September 30, 2025. Loans past-due 30-89 days and still accruing interest increased to $3.4 million, or 0.23% of total loans on September 30, 2026, $2.5 million, or 0.17% of total loans on June 30, 2026, and $3.6 million, or 0.25%, of total loans on September 30, 2025. The health care provider portfolio balance continues to decline with $7.9 million in loan balances and $3.0 million in remaining unamortized premiums. The portfolio has loans totaling $1.4 million currently on non-accrual that are specifically reserved at $1.0 million.

CAPITAL

During the third quarter of 2026, the Company declared and paid cash dividends of $0.17 per common share, compared to $0.17 in the second quarter of 2026 and $0.155 in the third quarter of 2025. Tangible book value per share⁽¹⁾grew to $19.94 on September 30, 2026, from $19.71 per share on June 30, 2026, and $18.26 on September 30, 2025.

The following table provides capital ratios and values for the periods ended:

First National Corporation ⁽²⁾	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025
Total risk-based capital ratio		15.14	%		14.81	%		15.15	%
Tier 1 risk-based capital ratio		13.59	%		13.22	%		12.83	%
Common equity Tier 1 capital ratio		12.98	%		12.60	%		12.20	%
Leverage ratio		10.00	%		9.62	%		9.24	%
Tangible common equity to tangible assets⁽¹⁾		8.77	%		8.65	%		8.17	%
Tangible book value per share ⁽¹⁾	$	19.94		$	19.71		$	18.26

First Bank	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025
Total risk-based capital ratio ⁽³⁾		14.19	%		13.91	%		13.40	%
Tier 1 risk-based capital ratio ⁽³⁾		13.20	%		12.87	%		12.36	%
Common equity Tier 1 capital ratio ⁽³⁾		13.20	%		12.87	%		12.36	%
Leverage ratio ⁽³⁾		9.77	%		9.44	%		8.88	%
Tangible common equity to tangible assets ⁽¹⁾		8.82	%		8.75	%		8.18	%

ABOUT FIRST NATIONAL CORPORATION

First National Corporation (NASDAQ: FXNC) is the parent company and bank holding company of First Bank, a community bank that first opened for business in 1907 in Strasburg, Virginia. The Bank offers loan and deposit products and services through its bankers, consumer and business mobile banking platforms, a network of ATMs located throughout its market area, a loan production office, a customer service center in a retirement community, and twenty-eight banking office locations located throughout the Shenandoah Valley, the Roanoke Valley, the Richmond MSA, and the south-central regions of Virginia. In addition to providing traditional banking services, the Bank operates a wealth management division under the name First Bank Wealth Management. First Bank also owns First Bank Financial Services, Inc., which owns an interest in a title insurance company.

NON-GAAP FINANCIAL MEASURES

In addition to financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), the Company uses certain non-GAAP financial measures that provide useful information for financial and operational decision making, evaluating trends, and comparing financial results to other financial institutions. The non-GAAP financial measures presented in this document include adjusted operating net income, adjusted operating non-interest expense, adjusted basic and diluted earnings per share, adjusted return on average assets, adjusted return on average equity, pre-provision pre-tax earnings, adjusted pre-provision pre-tax earnings, fully taxable equivalent interest income, the fully tax-equivalent net interest margin, the efficiency ratio, tangible book value per share, and tangible common equity to tangible assets.

The Company believes certain non-GAAP financial measures enhance the understanding of its business and performance. Non-GAAP financial measures are supplemental and not a substitute for, or more important than, financial measures prepared in accordance with GAAP and may not be comparable to those reported by other financial institutions. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measure is included at the end of this release.

FORWARD-LOOKING STATEMENTS

Certain information contained in this discussion may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to the Company’s plans, objectives, strategies, expectations and intentions, including with respect to the Company’s branch sales and other branch optimization initiatives, and other statements that are not historical facts, and other statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “will,” “continue,” and “projects,” as well as similar expressions. Although the Company believes that its expectations with respect to the forward-looking statements are based upon reliable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that the Company will achieve the anticipated benefits of its plans and strategies or that its actual results, performance, or achievements will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties and speak only as of the date of this release. The Company undertakes no obligations to update or revise any forward-looking statement, except as required by law. For details on factors that could affect expectations, future events, or results, see the risk factors and other cautionary language included in First National Corporation’s Annual Report on Form 10-K for the year ended December 31, 2025 and other filings with the Securities and Exchange Commission (the “SEC”).

CONTACTS

Scott C. Harvard		Brad E. Schwartz
President and CEO		Executive Vice President and CFO
(540) 545-7695		(540) 465-6130
sharvard@fbvirginia.com		bschwartz@fbvirginia.com

FIRST NATIONAL CORPORATION Performance Summary (in thousands)
(unaudited)
	For the Three Months Ended								For the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026		Sept 30, 2025			Sept 30, 2026		Sept 30, 2025
Income Statement
Interest and dividend income
Interest and fees on loans	$	23,496		$	22,145	$	21,430		$	66,658	$	63,661
Interest on deposits in banks		1,169		$	1,288		1,733			3,627		5,295
Interest on federal funds sold		—			—		1			—		40
Taxable interest on securities		1,899			1,843		1,562			5,528		4,189
Tax-exempt interest on securities		292			293		296			877		894
Dividends		64			64		65			192		194
Total interest and dividend income	$	26,920		$	25,633	$	25,087		$	76,882	$	74,273
Interest expense
Interest on deposits	$	5,471		$	5,410	$	6,246		$	16,295	$	18,363
Interest on subordinated debt		171			170		479			509		1,414
Interest on junior subordinated debt		69			69		67			204		199
Interest on other borrowings		3			3		—			11		3
Total interest expense	$	5,714		$	5,652	$	6,792		$	17,019	$	19,979
Net interest income	$	21,206		$	19,981	$	18,295		$	59,863	$	54,294
Provision for credit losses		—			426		193			876		1,936
Net interest income after provision for credit losses	$	21,206		$	19,555	$	18,102		$	58,987	$	52,358
Noninterest income
Service charges on deposit accounts	$	940		$	913	$	985		$	2,777	$	3,018
ATM and check card fees		1,143			1,155		1,336			3,345		3,460
Wealth management fees		1,009			902		910			2,822		2,675
Fees for other customer services		334			295		407			916		895
Brokered mortgage fees		79			153		166			347		459
Income from bank owned life insurance		289			241		284			789		761
Net (loss) gains on securities available for sale		—			—		—			8		—
Net gains on sale of loans held for sale		46			4		5			51		5
Bargain purchase gain		—			—		304			—		304
Net gain on subordinated debt payoff		—			—		—			—		80
(Loss) gain on disposal of premises and equipment		(12	)		56		—			44		—
Other operating income		256			299		103			827		343
Total noninterest income	$	4,084		$	4,018	$	4,500		$	11,926	$	12,000
Noninterest expense
Salaries and employee benefits	$	9,341		$	9,006	$	8,487		$	27,329	$	25,209
Occupancy		1,002			974		1,025			2,948		3,038
Equipment		1,067			1,131		1,056			3,291		3,138
Marketing		353			476		324			1,170		830
Supplies		199			192		158			537		573
Legal and professional fees		646			742		660			2,076		1,775
ATM and check card expense		629			608		569			1,808		1,545
FDIC assessment		254			224		305			705		1,034
Bank franchise tax		395			395		350			1,170		1,015
Data processing expense		435			435		495			1,264		1,761
Core deposit intangible amortization expense		434			433		442			1,301		1,325
Other real estate owned expense (income), net		212			—		—			212		(7	)
Net loss on disposal of premises and equipment		—			—		(23	)		—		(16	)
Merger expense		—			—		—			—		2,032
Other operating expense		1,729			1,821		1,934			5,304		6,056
Total noninterest expense	$	16,696		$	16,437	$	15,782		$	49,115	$	49,308
Income before income taxes	$	8,594		$	7,136	$	6,820		$	21,798	$	15,050
Income tax expense		1,694			1,393		1,270			4,268		2,851
Net income	$	6,900		$	5,743	$	5,550		$	17,530	$	12,199

FIRST NATIONAL CORPORATION Performance Summary (in thousands, except share and per share data)
(unaudited)
	At or for the Three Months Ended									At or for the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025			Sept 30, 2026			Sept 30, 2025
Common Share and Per Common Share Data
Earnings per common share, basic	$	0.76		$	0.64		$	0.62		$	1.94		$	1.36
Adjusted earnings per common share, basic ⁽¹⁾	$	0.76		$	0.64		$	0.58		$	1.94		$	1.51
Weighted average shares, basic		9,050,059			9,041,314			8,999,153			9,041,056			8,988,692
Earnings per common share, diluted	$	0.76		$	0.63		$	0.62		$	1.93		$	1.35
Adjusted earnings per common share, diluted ⁽¹⁾	$	0.76		$	0.63		$	0.58		$	1.93		$	1.50
Weighted average shares, diluted		9,084,052			9,068,347			9,023,185			9,066,673			9,010,432
Shares outstanding at period end		9,057,224			9,042,629			9,009,209			9,057,224			9,009,209
Tangible book value per share at period end ⁽¹⁾	$	19.94		$	19.71		$	18.26		$	19.94		$	18.26
Market price per share at period end	$	29.38		$	30.02		$	22.68		$	29.38		$	22.68
Cash dividends declared	$	0.170		$	0.170		$	0.155		$	0.510		$	0.465

Key Performance Ratios
Return on average assets ⁽⁴⁾		1.32	%		1.11	%		1.09	%		1.15	%		0.81	%
Adjusted return on average assets ⁽¹⁾⁽⁴⁾		1.32	%		1.11	%		1.03	%		1.15	%		0.90	%
Return on average equity ⁽⁴⁾		14.02	%		12.03	%		12.43	%		12.26	%		9.47	%
Adjusted return on average equity ⁽¹⁾⁽⁴⁾		14.02	%		12.03	%		11.75	%		12.26	%		10.50	%
Net interest margin ⁽⁴⁾		4.36	%		4.13	%		3.83	%		4.17	%		3.83	%
Net interest margin fully tax equivalent⁽¹⁾⁽⁴⁾		4.38	%		4.15	%		3.84	%		4.19	%		3.85	%
Efficiency ratio ⁽¹⁾		63.21	%		66.59	%		67.97	%		66.11	%		69.46	%

Average Balances
Average assets	$	2,065,812		$	2,079,467		$	2,022,958		$	2,047,838		$	2,021,263
Average earning assets		1,930,945			1,941,385			1,897,328			1,925,959			1,892,933
Average deposits		1,843,968			1,861,554			1,806,310			1,829,463			1,808,016
Average noninterest deposits to total average deposits		28.98	%		29.15	%		29.13	%		28.32	%		29.35	%
Average shareholders’ equity	$	195,262		$	191,465		$	177,130			191,909		$	172,297

Asset Quality
Allowance for credit losses on loans to nonperforming assets		267.70	%		315.45	%		253.37	%		267.70	%		253.37	%
Allowance for credit losses on loans to period end loans		0.96	%		1.00	%		1.01	%		0.96	%		1.01	%
Nonperforming assets to period end loans		0.36	%		0.32	%		0.40	%		0.36	%		0.40	%
Nonperforming assets to total assets		0.26	%		0.23	%		0.28	%		0.26	%		0.28	%
Non-accrual loans to period end loans		0.31	%		0.32	%		0.40	%		0.31	%		0.40	%
Non-accrual loans to total assets		0.22	%		0.23	%		0.28	%		0.22	%		0.28	%
Loan charge-offs	$	728		$	266		$	1,027		$	1,703		$	4,052
Loan recoveries		134			161			88			462			264
Net charge-offs		594			105			939			1,241			3,788
Non-accrual loans		4,637			4,737			5,702			4,637			5,702
Other real estate owned, net		747			—			—			747			—
Nonperforming assets		5,384			4,737			5,702			5,384			5,702
Loans 30 to 89 days past due, accruing		3,408			2,534			3,580			3,408			3,580
Loans over 90 days past due, accruing		—			—			388			—			388

Capital Ratios ⁽⁵⁾
Total capital	$	215,522		$	210,436		$	194,910		$	215,522		$	194,910
Tier 1 capital		200,457			194,778			179,781			200,457			179,781
Common equity Tier 1 capital		200,457			194,778			179,781			200,457			179,781
Total capital to risk-weighted assets ⁽³⁾		14.19	%		13.91	%		13.40	%		14.19	%		13.40	%
Tier 1 capital to risk-weighted assets ⁽³⁾		13.20	%		12.87	%		12.36	%		13.20	%		12.36	%
Common equity Tier 1 capital / risk-weighted assets ⁽³⁾		13.20	%		12.87	%		12.36	%		13.20	%		12.36	%
Leverage ratio ⁽³⁾		9.77	%		9.44	%		8.88	%		9.77	%		8.88	%

FIRST NATIONAL CORPORATION Performance Summary (in thousands)
(unaudited)
	For the Period Ended
	Sept 30, 2026			Jun 30, 2026			Mar 31, 2026			Dec 31, 2025			Sept 30, 2025
Balance Sheet
Cash and due from banks	$	25,996		$	23,294		$	22,624		$	20,836		$	23,716
Interest-bearing deposits in banks		141,580			142,854			165,185			140,074			165,601
Cash and cash equivalents	$	167,576		$	166,148		$	187,809		$	160,910		$	189,317
Securities available for sale, at fair value		218,668			227,792			217,655			217,538			196,476
Securities held to maturity, at amortized cost (net of allowance for credit losses)		82,513			89,392			101,261			102,872			104,608
Restricted securities, at cost		5,642			5,642			5,642			5,624			4,436
Loans held for sale		262			—			—			—			—
Loans, net of allowance for credit losses		1,485,813			1,472,455			1,449,708			1,435,026			1,418,750
Other real estate owned, net		747			—			—			—			—
Premises and equipment, net		33,162			34,021			34,327			34,561			34,107
Accrued interest receivable		6,732			6,517			6,656			6,467			6,238
Bank owned life insurance		39,371			39,077			38,837			38,577			38,652
Goodwill		3,030			3,030			3,030			3,030			3,030
Core deposit intangibles, net		11,918			12,352			12,785			13,219			13,661
Other assets		19,426			19,219			18,113			20,154			21,479
Total assets	$	2,074,860		$	2,075,645		$	2,075,823		$	2,037,978		$	2,030,754

Noninterest-bearing demand deposits	$	520,058		$	520,548		$	524,323		$	509,874		$	511,482
Savings and interest-bearing demand deposits		951,409			953,639			953,399			926,579			931,241
Time deposits		357,273			356,943			359,570			363,095			366,860
Total deposits	$	1,828,740		$	1,831,130		$	1,837,292		$	1,799,548		$	1,809,583
Other borrowings		25,000			25,000			25,000			25,000			—
Subordinated debt, net		8,537			8,460			8,385			8,312			21,241
Junior subordinated debt		9,279			9,279			9,279			9,279			9,279
Accrued interest payable and other liabilities		7,751			8,188			7,305			9,643			9,442
Total liabilities	$	1,879,307		$	1,882,057		$	1,887,261		$	1,851,782		$	1,849,545

Common stock		11,320			11,303			11,301			11,282			11,262
Surplus		79,284			78,667			78,400			78,216			78,187
Retained earnings		121,854			116,494			112,288			108,937			104,964
Accumulated other comprehensive (loss), net		(16,905	)		(12,876	)		(13,427	)		(12,239	)		(13,204	)
Total shareholders’ equity	$	195,553		$	193,588		$	188,562		$	186,196		$	181,209
Total liabilities and shareholders’ equity	$	2,074,860		$	2,075,645		$	2,075,823		$	2,037,978		$	2,030,754

Loan Portfolio
Real estate loans:
Construction and land development	$	99,991		$	113,289		$	97,487		$	88,424		$	78,470
Secured by farmland		10,199			10,348			11,554			11,879			12,812
Secured by 1-4 family residential		526,563			522,763			520,821			527,282			533,458
Other real estate loans		739,805			709,772			701,013			685,099			671,723
Commercial and industrial loans (except those secured by real estate)		106,134			113,205			114,517			117,256			117,047
Consumer installment loans		7,673			8,105			8,060			8,419			8,358
Deposit overdrafts		647			478			547			543			535
All other loans		9,214			9,438			10,407			10,843			10,794
Total loans	$	1,500,226		$	1,487,398		$	1,464,406		$	1,449,745		$	1,433,197
Allowance for credit losses		(14,413	)		(14,943	)		(14,698	)		(14,719	)		(14,447	)
Loans, net	$	1,485,813		$	1,472,455		$	1,449,708		$	1,435,026		$	1,418,750

FIRST NATIONAL CORPORATION Average Balances, Yields and Rates Paid (in thousands)
(unaudited)	Three Months Ended
	September 30, 2026							June 30, 2026							September 30, 2025
	Average Balance			Interest Income/ Expense		Yield/ Rate⁽⁷⁾		Average Balance			Interest Income/ Expense		Yield/ Rate⁽⁷⁾		Average Balance			Interest Income/ Expense		Yield/ Rate⁽⁷⁾
Assets
Securities:
Taxable	$	250,906		$	1,899	3.00	%	$	256,750		$	1,843	2.88	%	$	242,797		$	1,562	2.55	%
Tax-exempt⁽¹⁾		62,745			370	2.33	%		62,353			372	2.39	%		51,493			375	2.89	%
Restricted		4,468			64	5.66	%		4,468			64	5.76	%		4,436			65	5.80	%
Total securities	$	318,119		$	2,333	2.91	%	$	323,571		$	2,279	2.82	%	$	298,726		$	2,002	2.66	%
Loans:
Taxable	$	1,483,047		$	23,452	6.27	%	$	1,473,064		$	22,103	6.02	%	$	1,437,946		$	21,386	5.90	%
Tax-exempt ⁽¹⁾		3,463			55	6.34	%		3,460			54	6.31	%		3,473			55	6.29	%
Total loans	$	1,486,510		$	23,507	6.27	%	$	1,476,524		$	22,157	6.02	%	$	1,441,419		$	21,441	5.90	%
Federal funds sold		13			—	—			1			—	—			55			—	—
Interest-bearing deposits with other institutions		126,303			1,169	3.67	%		141,289			1,287	3.66	%		157,128			1,734	4.38	%
Total earning assets	$	1,930,945		$	27,009	5.55	%	$	1,941,385		$	25,723	5.31	%	$	1,897,328		$	25,177	5.26	%
Less: allowance for credit losses on loans		(15,193	)						(15,039	)						(15,378	)
Total non-earning assets		150,060							153,121							141,008
Total assets	$	2,065,812						$	2,079,467						$	2,022,958
Liabilities and Shareholders’ Equity
Interest bearing deposits:
Checking	$	409,383		$	1,138	1.10	%	$	416,041		$	1,101	1.06	%	$	376,344		$	1,256	1.32	%
Regular savings		210,192			173	0.33	%		212,451			171	0.32	%		209,909			208	0.39	%
Money market accounts		332,549			1,582	1.89	%		335,904			1,573	1.88	%		330,115			1,882	2.26	%
Time deposits		357,452			2,578	2.86	%		354,558			2,565	2.90	%		363,702			2,900	3.16	%
Total interest-bearing deposits	$	1,309,576		$	5,471	1.66	%	$	1,318,954		$	5,410	1.65	%	$	1,280,070		$	6,246	1.94	%
Federal funds purchased		5			—	—			2			—	—			—			—	—
Subordinated debt		8,498			171	8.02	%		8,422			170	8.09	%		21,304			479	8.92	%
Junior subordinated debt		9,279			69	2.95	%		9,279			69	2.96	%		9,279			67	2.83	%
Other borrowings		272			3	4.19	%		275			3	3.93	%		—			—	—
Total interest-bearing liabilities	$	1,327,630		$	5,714	1.71	%	$	1,336,932		$	5,652	1.70	%	$	1,310,653		$	6,792	2.06	%
Non-interest bearing liabilities
Demand deposits		534,392							542,600							526,240
Other liabilities		8,528							8,470							8,935
Total liabilities	$	1,870,550						$	1,888,002						$	1,845,828
Shareholders’ equity		195,262							191,465							177,130
Total liabilities and Shareholders’ equity	$	2,065,812						$	2,079,467						$	2,022,958
Net interest income⁽¹⁾				$	21,295						$	20,071						$	18,385
Interest rate spread⁽¹⁾						3.84	%						3.61	%						3.21	%
Cost of funds						1.22	%						1.21	%						1.47	%
Interest expense as a percent of average earning assets						1.17	%						1.17	%						1.42	%
Net interest margin FTE ⁽¹⁾						4.38	%						4.15	%						3.84	%

FIRST NATIONAL CORPORATION Average Balances, Yields and Rates Paid (in thousands)
(unaudited)	Nine Months Ended
	September 30, 2026							September 30, 2025
	Average Balance			Interest Income/ Expense		Yield / Rate ⁽⁷⁾		Average Balance			Interest Income/ Expense		Yield / Rate ⁽⁷⁾
Assets
Securities:
Taxable	$	255,719		$	5,528	2.90	%	$	227,643		$	4,189	2.46	%
Tax-exempt ⁽¹⁾		62,225			1,110	2.39	%		51,380			1,132	2.95	%
Restricted		4,467			192	5.78	%		4,353			194	5.96	%
Total securities	$	322,411		$	6,830	2.84	%	$	283,376		$	5,515	2.60	%
Loans:
Taxable	$	1,467,572		$	66,529	6.08	%	$	1,444,739		$	63,513	5.88	%
Tax-exempt ⁽¹⁾		3,468			163	6.34	%		4,117			187	6.08	%
Total loans	$	1,471,040		$	66,692	6.08	%	$	1,448,856		$	63,700	5.88	%
Federal funds sold		17			—	—			1,182			40	4.52	%
Interest-bearing deposits with other institutions		132,491			3,627	3.67	%		159,519			5,295	4.44	%
Total earning assets	$	1,925,959		$	77,149	5.38	%	$	1,892,933		$	74,550	5.27	%
Less: allowance for credit losses on loans		(15,091	)						(15,624	)
Total non-earning assets		136,970							143,954
Total assets	$	2,047,838						$	2,021,263
Liabilities and Shareholders’ Equity
Interest bearing deposits:
Checking	$	409,527		$	3,317	1.09	%	$	370,045		$	3,696	1.34	%
Regular savings		211,231			521	0.33	%		211,635			574	0.36	%
Money market accounts		333,069			4,647	1.87	%		332,864			5,713	2.30	%
Time deposits		357,495			7,810	2.93	%		362,860			8,380	3.09	%
Total interest-bearing deposits	$	1,311,322		$	16,295	1.67	%	$	1,277,404		$	18,363	1.92	%
Federal funds purchased		9			—	—			1			—	—
Subordinated debt		8,423			509	8.11	%		22,500			1,414	8.40	%
Junior subordinated debt		9,279			204	2.95	%		9,279			199	2.86	%
Other borrowings		366			11	4.01	%		92			3	4.63	%
Total interest-bearing liabilities	$	1,329,399		$	17,019	1.72	%	$	1,309,276		$	19,979	2.04	%
Non-interest bearing liabilities
Demand deposits		518,141							530,612
Other liabilities		8,389							9,078
Total liabilities	$	1,855,929						$	1,848,966
Shareholders’ equity		191,909							172,297
Total liabilities and Shareholders’ equity	$	2,047,838						$	2,021,263
Net interest income⁽¹⁾				$	60,130						$	54,571
Interest rate spread ⁽¹⁾						3.66	%						3.23	%
Cost of funds						1.24	%						1.45	%
Interest expense as a percent of average earning assets						1.19	%						1.41	%
Net interest margin FTE ⁽¹⁾						4.19	%						3.85	%

FIRST NATIONAL CORPORATION Non-GAAP Reconciliation (in thousands, except share and per share data)
(unaudited)
	For the Three Months Ended									For the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025			Sept 30, 2026			Sept 30, 2025
Operating Net Income
Net income (GAAP)	$	6,900		$	5,743		$	5,550		$	17,530		$	12,199
Add: Merger-related expenses		—			—			—			—			2,032
Subtract: Bargain purchase gain		—			—			(304	)		—			(304	)
Subtract: Tax effect of adjustment (6)		—			—			64			—			(327	)
Adjusted operating net income (non-GAAP)	$	6,900		$	5,743		$	5,310		$	17,530		$	13,600

Adjusted Earnings Per Share, Basic
Weighted average shares, basic		9,050,059			9,041,314			8,999,153			9,041,056			8,988,692
Basic earnings per share (GAAP)	$	0.76		$	0.64		$	0.62		$	1.94		$	1.36
Adjusted earnings per share, basic (non-GAAP)	$	0.76		$	0.64		$	0.58		$	1.94		$	1.51

Adjusted Earnings Per Share, Diluted
Weighted average shares, diluted		9,084,052			9,068,347			9,023,185			9,066,673			9,010,432
Diluted earnings per share (GAAP)	$	0.76		$	0.63		$	0.62		$	1.93		$	1.35
Adjusted diluted earnings per share (non-GAAP)	$	0.76		$	0.63		$	0.58		$	1.93		$	1.50

Adjusted Pre-Provision, Pre-Tax Earnings
Net interest income	$	21,206		$	19,981		$	18,295		$	59,863		$	54,294
Total noninterest income		4,084			4,018			4,500			11,926			12,000
Net revenue	$	25,290		$	23,999		$	22,795		$	71,789		$	66,294
Total noninterest expense		16,696			16,437			15,782			49,115			49,308
Pre-provision, pre-tax earnings (non-GAAP)	$	8,594		$	7,562		$	7,013		$	22,674		$	16,986
Add: Merger expenses		—			—			—			—			2,032
Subtract: Bargain purchase gain		—			—			(304	)		—			(304	)
Adjusted pre-provision, pre-tax earnings (non-GAAP)	$	8,594		$	7,562		$	6,709		$	22,674		$	18,714

Adjusted Performance Ratios
Average assets	$	2,065,812		$	2,079,467		$	2,022,958		$	2,047,838		$	2,021,263
Return on average assets (GAAP)		1.32	%		1.11	%		1.09	%		1.15	%		0.81	%
Adjusted return on average assets (non-GAAP)		1.32	%		1.11	%		1.03	%		1.15	%		0.90	%

Average shareholders’ equity	$	195,262		$	191,465		$	177,130		$	191,909		$	172,297
Return on average equity (GAAP)		14.02	%		12.03	%		12.43	%		12.26	%		9.47	%
Adjusted return on average equity (non-GAAP)		14.02	%		12.03	%		11.75	%		12.26	%		10.50	%

Net Interest Margin
Net interest income	$	21,206		$	19,981		$	18,295		$	59,863		$	54,294
Tax-equivalent net interest income (non-GAAP)		21,295			20,071			18,385			60,130			54,571
Average earning assets		1,930,945			1,941,385			1,897,328			1,925,959			1,892,933
Net interest margin		4.36	%		4.13	%		3.83	%		4.17	%		3.83	%
Net interest margin fully tax equivalent (non-GAAP)		4.38	%		4.15	%		3.84	%		4.19	%		3.85	%

FIRST NATIONAL CORPORATION Non-GAAP Reconciliation (in thousands)
(unaudited)	For the Three Months Ended									For the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025			Sept 30, 2026			Sept 30, 2025
Adjusted Operating Noninterest Expense
Total noninterest expense (GAAP)	$	16,696		$	16,437		$	15,782		$	49,115		$	49,308
Subtract: merger expenses		—			—			—			—			(2,032	)
Subtract: amortization expense		(434	)		(433	)		(442	)		(1,301	)		(1,325	)
Adjusted operating noninterest expense (non-GAAP)	$	16,262		$	16,004		$	15,340		$	47,814		$	45,951

Efficiency Ratio
Total noninterest expense (GAAP)	$	16,696		$	16,437		$	15,782		$	49,115		$	49,308
Subtract/Add: other real estate owned (expense) income, net		(212	)		—			—			(212	)		7
Subtract: amortization of intangibles		(434	)		(433	)		(442	)		(1,301	)		(1,325	)
Add: gain on disposal of premises and equipment, net		—			—			9			—			16
Subtract: merger expenses		—			—			—			—			(2,032	)
Adjusted operating non-interest expense (non-GAAP)	$	16,050		$	16,004		$	15,349		$	47,602		$	45,974
Tax-equivalent net interest income (non-GAAP)	$	21,295		$	20,071		$	18,385		$	60,130		$	54,571
Total noninterest income (GAAP)		4,084			4,018			4,500			11,926			12,000
Add/Subtract: loss (gain) on disposal of premises and equipment		12			(56	)		—			(44	)		—
Subtract: net (gain) on subordinated debt payoff		—			—			—			—			(80	)
Subtract: bargain purchase gain		—			—			(304	)		—			(304	)
Subtract: securities (gains), net		—			—			—			(8	)		—
Adjusted income for efficiency ratio (non-GAAP)	$	25,391		$	24,033		$	22,581		$	72,004		$	66,187

Efficiency ratio (non-GAAP)		63.21	%		66.59	%		67.97	%		66.11	%		69.46	%

FIRST NATIONAL CORPORATION Non-GAAP Reconciliation (in thousands, except share and per share data)
(unaudited)
	For the Three Months Ended									For the Nine Months Ended
	Sept 30, 2026			Jun 30, 2026			Sept 30, 2025			Sept 30, 2026			Sept 30, 2025
Tax-Equivalent Net Interest Income
GAAP measures:
Interest income – loans	$	23,496		$	22,145		$	21,430		$	66,658		$	63,661
Interest income – investments and other		3,424			3,488			3,657			10,224			10,612
Interest expense – deposits		(5,471	)		(5,410	)		(6,246	)		(16,295	)		(18,363	)
Interest expense – subordinated debt		(171	)		(170	)		(479	)		(509	)		(1,414	)
Interest expense – junior subordinated debt		(69	)		(69	)		(67	)		(204	)		(199	)
Interest expense – other borrowings		(3	)		(3	)		—			(11	)		(3	)
Net interest income	$	21,206		$	19,981		$	18,295		$	59,863		$	54,294
Non-GAAP measures:
Add: Tax benefit realized on non-taxable interest income – loans ⁽⁶⁾	$	11		$	12		$	11		$	34		$	39
Add: Tax benefit realized on non-taxable interest income – municipal securities ⁽⁶⁾		78			78			79			233			238
Tax benefit realized on non-taxable interest income	$	89		$	90		$	90		$	267		$	277
Tax-equivalent net interest income (non-GAAP)	$	21,295		$	20,071		$	18,385		$	60,130		$	54,571

Tangible Common Equity and Tangible Assets
Total assets (GAAP)	$	2,074,860		$	2,075,645		$	2,030,754		$	2,074,860		$	2,030,754
Subtract: goodwill		(3,030	)		(3,030	)		(3,030	)		(3,030	)		(3,030	)
Subtract: core deposit intangibles, net		(11,918	)		(12,352	)		(13,661	)		(11,918	)		(13,661	)
Tangible assets (Non-GAAP)	$	2,059,912		$	2,060,263		$	2,014,063		$	2,059,912		$	2,014,063

Total shareholders’ equity (GAAP)	$	195,553		$	193,588		$	181,209		$	195,553		$	181,209
Subtract: goodwill		(3,030	)		(3,030	)		(3,030	)		(3,030	)		(3,030	)
Subtract: core deposit intangibles, net		(11,918	)		(12,352	)		(13,661	)		(11,918	)		(13,661	)
Tangible common equity (Non-GAAP)	$	180,605		$	178,206		$	164,518		$	180,605		$	164,518

Tangible common equity to tangible assets ratio (non-GAAP)		8.77	%		8.65	%		8.17	%		8.77	%		8.17	%

Tangible Book Value Per Share
Tangible common equity (non-GAAP)	$	180,605		$	178,206		$	164,518		$	180,605		$	164,518
Common shares outstanding, ending		9,057,224			9,042,629			9,009,209			9,057,224			9,009,209
Tangible book value per share (non-GAAP)	$	19.94		$	19.71		$	18.26		$	19.94		$	18.26

⁽¹⁾	Non-GAAP financial measure. See “Non-GAAP Financial Measures” and “Non-GAAP Reconciliation” tables for additional information and detailed calculations of adjustments.
⁽²⁾	The Company is a small bank holding company under applicable regulations and guidance and is not subject to the minimum regulatory capital regulations for bank holding companies. The regulatory requirements that apply to bank holding companies that are subject to regulatory capital requirements are presented below, along with the Company’s capital ratios as determined under those regulations.
⁽³⁾	All ratios on September 30, 2026, are estimates and subject to change pending the Bank’s filing of its Call Report. All other periods are presented as filed.
⁽⁴⁾	Ratios are annualized.
⁽⁵⁾	Capital ratios presented are for First Bank.
⁽⁶⁾	The tax rate utilized in calculating the tax benefit is 21%.
⁽⁷⁾	Yields and interest income are presented on a taxable-equivalent basis using the federal statutory tax rate of 21%.

Posted in UncategorizedTagged GlobeNewswire

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Posted on October 23, 2026 by Ravi Shankar

Additional $500,000 Advance to Support Growth Initiatives and Working Capital of Realbotix LLC

Total Drawn Under Facility Now $3,000,000; Non-Interest Bearing Facility Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition

CINCINNATI, Ohio, Oct. 23, 2026 (GLOBE NEWSWIRE) — Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) today announced that it has made an additional advance of $500,000 to Realbotix LLC (“Realbotix”), the target of its previously announced pending acquisition, under the strategic bridge financing facility (the “Grid Note”) announced on September 14, 2026. The additional advance brings the total principal outstanding under the facility to $3,000,000.

As previously disclosed, the Grid Note provides for aggregate loans of up to $5,000,000 and is non-interest bearing prior to the closing of the Share Exchange Agreement. Upon closing, the Grid Note and all obligations thereunder will be automatically cancelled and discharged in full. The cash required at closing will be reduced by the total principal advanced under the Grid Note plus an additional $500,000. If the Share Exchange Agreement is terminated, interest accrues at 12% per annum from the date of termination.

A description of the additional advance is included in Onconetix’s Current Report on Form 8-K filed with the SEC on October 23, 2026. The full text of the Note is available at www.sec.gov.

As previously announced on February 12, 2026, Onconetix entered into the Share Exchange Agreement to acquire 100% of the issued and outstanding equity interests of Realbotix LLC in an all-stock transaction. The combined company is expected to trade on Nasdaq following closing, which is subject to Onconetix shareholder approval, required regulatory approvals, and other closing conditions.

This communication is being provided for informational purposes only. Investors are cautioned not to place undue reliance on forward-looking or projected information.

About Onconetix, Inc.

Onconetix, Inc. (Nasdaq: ONCO) is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative oncology solutions. Onconetix owns Proclarix®, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union under the IVDR, which it anticipates will be marketed in the U.S. as a lab developed test through its license agreement with Labcorp. For more information, visit www.onconetix.com.

About Realbotix LLC

Realbotix LLC is a wholly-owned subsidiary of Realbotix Corp. (TSX-V: XBOT; Frankfurt: 76M0.F; OTC: XBOTF) and the target of Onconetix’s pending acquisition. Realbotix LLC develops AI-powered humanoid robots designed for human interaction across enterprise and consumer environments. Manufactured in the United States, Realbotix’s patented AI and robotics technologies enable lifelike expressions, motion, vision, and social engagement. For more information, visit www.realbotix.ai.

Additional Information and Where to Find It

In connection with the proposed transaction between Realbotix and Onconetix, Onconetix intends to file with the SEC a Registration Statement on Form S-4 (the “Registration Statement”) to register the common stock to be issued by Onconetix in connection with the proposed transaction. The Registration Statement will include a proxy statement of Onconetix and a prospectus of Onconetix (the “Proxy Statement/Prospectus”), and each of Realbotix and Onconetix may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Proxy Statement/Prospectus will be sent to the stockholders of Onconetix to seek their approval of the proposed transaction. This is not a substitute for the Registration Statement, the Proxy Statement/Prospectus or any other relevant documents that Realbotix or Onconetix has filed or will file with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF ONCONETIX ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENT AND PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT REALBOTIX, ONCONETIX, THE PROPOSED TRANSACTION, AND RELATED MATTERS.

A copy of the Registration Statement, Proxy Statement/Prospectus, as well as other relevant documents filed by Realbotix and Onconetix with the SEC, may be obtained free of charge, when they become available, at the SEC’s website at www.sec.gov. The information on Realbotix or Onconetix’s respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.

Participants in the Solicitation

Realbotix, Onconetix and certain of their respective directors, executive officers, and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Onconetix, their ownership of Onconetix common stock, and Onconetix’s transactions with related persons is set forth in the 10-K, as filed with the SEC on March 13, 2026, and other documents that may be filed from time to time with the SEC. Additional information about the directors and executive officers of Realbotix and Onconetix and other persons who may be deemed to be participants in the solicitation of stockholders of Onconetix in connection with the proposed transaction and a description of their direct and indirect interests will be included in the Proxy Statement/Prospectus related to the proposed transaction or other relevant materials, which will be filed with the SEC. These documents may be obtained free of charge, when they become available, at the SEC’s website at www.sec.gov and from Onconetix using the sources indicated above.

No Offer or Solicitation

This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.

Forward-Looking Statements

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements (including, without limitation, the anticipated benefits and opportunities that may be generated by the proposed transaction described herein) are based on Onconetix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the occurrence of any event, change, or other circumstances that could give rise to the right of one or both of the parties to terminate the share exchange agreement; the possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not satisfied on a timely basis or at all, including the failure to timely obtain stockholder approval for the proposed transaction from Onconetix’s stockholders, if at all; risks related to Onconetix’s continued listing on Nasdaq until closing of the proposed transaction; the outcome of any legal proceedings that may be instituted against Realbotix, Onconetix, or the combined company; the possibility that the anticipated benefits of the proposed transaction are not realized when expected or at all; the possibility that the vision, goals, and trajectory of the combined company are not timely achieved or realized or achieved or realized at all; the possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events; the diversion of management’s attention from ongoing business operations and opportunities; changes in Onconetix’s stock price before closing; and other factors that may affect future results of Realbotix, Onconetix, or the combined company. Onconetix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in Onconetix’s Annual Report on Form 10-K filed with the SEC on March 13, 2026 (the “10-K”) and periodic reports filed with the SEC on or after the date thereof. All of Onconetix’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date thereof.

Investor and Media Contact:

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

Phone: (513) 620-4101

Email: investors@onconetix.com

Posted in UncategorizedTagged GlobeNewswire

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

Posted on October 23, 2026 by Ravi Shankar

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 third quarter financial results before the market opens on Friday, October 30, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI7e9cb633a38e45258f691f2b6d592419 Once registered, a dial-in number, unique pin, and instructions will be provided to participants.
The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following the completion of the call.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services.

We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump systems (3860 and 3870) have a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solutions provide a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.

Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The Iradimed 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The Iradimed 3880 has a compact, lightweight design, allowing it to travel with the patient from the critical care unit to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the Iradimed 3880 include wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The Iradimed 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.

For more information, please visit www.iradimed.com.

Media Contact:
John Glenn
Chief Financial Officer
iRadimed Corporation
(407) 677-8022
InvestorRelations@iradimed.com

Posted in UncategorizedTagged GlobeNewswire

SoundThinking Announces General Availability of SafetySmart® Field Agent to All ShotSpotter Customers

Posted on October 23, 2026 by Ravi Shankar

AI-powered assistant helps public safety professionals turn complex operational data into faster insights and better-informed decisions

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, today announced the general availability of SafetySmart® Field Agent to all ShotSpotter agencies, marking the transition from the beta program announced in June to broader commercial availability. SoundThinking is making Field Agent available to ShotSpotter agencies at no additional charge for up to 20 users per agency during the first year.

Introduced earlier this year with more than 20 beta agencies, Field Agent helps public safety personnel turn operational information into actionable insights without overburdening limited analyst resources. Using natural-language questions, personnel can analyze ShotSpotter data, identify trends, and generate maps, charts, incident summaries and draft briefings. By combining analysis and reporting in a single conversational experience, Field Agent reduces manual tasks and helps personnel across the agency make better-informed operational decisions.

“Field Agent represents a new way for public safety professionals to put ShotSpotter intelligence to work,” said Ralph Clark, President and CEO of SoundThinking. “By making it easier to analyze gunfire activity, uncover patterns and generate actionable insights, we’re helping agencies make faster, better-informed decisions. And as we expand Field Agent to additional sources of operational data, we see even greater opportunities to bring the power of AI into everyday public safety operations.”

The potential applications extend across agency operations. For example, a police chief responding to questions from city leadership could ask Field Agent how gunfire activity has changed over the past month and receive charts and maps highlighting relevant trends. Similarly, a supervisor preparing for an upcoming shift could request a summary of recent gunfire incidents in a specific patrol area, including locations and time-of-day patterns, to help inform operational planning and deployment decisions.

SoundThinking is also developing Field Agent Skills, a new capability that will allow agencies to create reusable instructions for recurring tasks, such as preparing shift briefings and summarizing incident activity, saving time and improving consistency.

“Field Agent is helping us get more value from information we already have,” said Detective Lucas Roethlisberger, Intelligence Unit / Crime Gun Intelligence Center, St. Louis Metropolitan Police Department. “Instead of waiting for someone to pull data and build an analysis, our team can ask questions directly, identify patterns, and get useful insights much faster. What’s especially exciting is the potential to bring more of our operational data into that experience, giving our people a more complete picture to support better-informed decisions.”

Looking ahead, SoundThinking is expanding the types of information Field Agent can use to support operational decision-making. The company is testing additional agency data sources, including computer-aided dispatch (CAD) and records management system (RMS) information, while enabling agencies to incorporate relevant information through documents and spreadsheets.

SoundThinking is also developing integration with CrimeTracer, its law enforcement search engine, which will extend Field Agent’s capabilities to additional investigative and criminal justice information and create opportunities to bring AI-powered decision support to CrimeTracer’s extensive network of over 2,100 agencies. Beta availability is planned for November, with general availability targeted for early 2027.

As Field Agent expands across additional agency data sources, responsible AI remains foundational to its design. Human review and decision-making remain central to the workflow: the technology can accelerate searching, synthesis and analysis, but interpretation, validation and operational or investigative decisions remain with authorized personnel.

ShotSpotter agencies can contact their Customer Success Director or email support@soundthinking.com to activate Field Agent access. Attendees at the International Association of Chiefs of Police (IACP) Annual Conference and Exposition in Orlando, Fla., can see a demonstration at Booth 1109 during the exposition, Oct. 25–27, 2026.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the potential application and effectiveness of Field Agent and the timing of availability of Field Agent’s integration with CrimeTracer. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” or variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the company’s control. The company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the effect of the announcement of the potential acquisition of the company on the company’s business relationships, including with partners, customers and employees; the diversion of the company’s management’s time and attention from ongoing business operations and opportunities; the impact of global macroeconomic conditions on the company’s business; as well as other risk factors included in the company’s most recent annual report on Form 10-K and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the company undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations.

About SoundThinking
SoundThinking, Inc. (Nasdaq: SSTI) is a leading public safety technology company that delivers AI- and data-driven solutions for law enforcement, civic leadership, and security professionals. SoundThinking is trusted by approximately 300 customers and supports approximately 2,100 agencies to drive more efficient, effective, and equitable public safety outcomes. The company’s SafetySmart® platform includes ShotSpotter®, the leading acoustic gunshot detection system; CrimeTracer™, the leading law enforcement search engine; SafePointe®, an AI-based weapons detection system; PlateRanger™ (powered by Rekor®), a leading ALPR solution; and Field Agent, an AI layer that transforms public safety data into actionable intelligence. SoundThinking has been designated a Great Place to Work® Company.

Company Contact:
Alan Stewart, CFO
SoundThinking, Inc.
+1 (510) 794-3100
astewart@soundthinking.com

Investor Relations Contact:
Ankit Hira
Solebury Strategic Communications for SoundThinking, Inc.
+1 (203) 546-0444
SSTI@soleburystrat.com

Source: SoundThinking, Inc.

Posted in UncategorizedTagged GlobeNewswire

Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy

Posted on October 23, 2026 by Ravi Shankar

— Patient demographics consistent with prior studies of other agents in HCM and reflect real-world clinical practice —

— Mean baseline KCCQ-CSS of 59 shows considerable symptom burden at study entry –

— Substantial over enrollment strengthens statistical power and provides robust dataset to evaluate the efficacy and safety of sotagliflozin —

THE WOODLANDS, Texas, Oct. 23, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today provided an update on the baseline characteristics of the patients randomized into the ongoing pivotal Phase 3 SOtaglifloziN in Patients with SymptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM) clinical trial evaluating sotagliflozin in patients with symptomatic hypertrophic cardiomyopathy. The data will be presented in detail by Dr. Sharlene Day, M.D., Presidential Professor, Director of Translational Research of the Penn Cardiovascular Institute, University of Pennsylvania and co-chair of the SONATA-HCM steering committee, on Saturday, October 24, 2026, at 4:05 p.m. ET at the International HCM Summit in Boston, MA.

The patient enrollment profile of SONATA-HCM is consistent with the study’s inclusive design, which aimed to reflect real-world clinical practice. Patients were permitted to remain on stable background therapies, including cardiac myosin inhibitors, allowing evaluation of sotagliflozin in patients receiving currently available HCM treatments. Importantly, baseline demographic and clinical characteristics within both the non-obstructive (nHCM) and obstructive HCM (oHCM) cohorts were generally consistent with those reported in previous clinical studies of other agents in those respective patient populations, supporting the relevance of the SONATA-HCM study population to the broader HCM community.

In total, SONATA-HCM enrolled 542 patients across more than 130 sites in 20 countries, substantially exceeding the study’s target enrollment of 500 patients and a providing larger dataset that may further enhance the statistical power of the study to detect meaningful treatment effects on its primary efficacy endpoint. Among enrolled patients, 440 have nHCM and 102 have oHCM, positioning SONATA-HCM to evaluate sotagliflozin in a broad HCM population while emphasizing patients with non-obstructive disease, who currently have no FDA-approved disease-specific treatments.

The overall study population had a mean baseline Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) of 59, reflecting a considerable burden of symptoms and limitations in daily activities at study entry. KCCQ-CSS ranges from 0 to 100, with higher scores indicating better health status and fewer symptoms, demonstrating that the SONATA-HCM study population began the trial with substantial opportunity for improvement. The primary efficacy endpoint of the pivotal study is improvement in symptoms, as measured by change from baseline in KCCQ-CSS at Week 26.

“We designed SONATA-HCM to evaluate sotagliflozin in a broad and clinically relevant HCM population reflective of real-world clinical practice, and we are very pleased that the final study population met that objective,” said Craig Granowitz, M.D., Ph.D., senior vice president and chief medical officer of Lexicon. “The demographic and clinical characteristics of both the obstructive and non-obstructive HCM cohorts were generally consistent with those reported in previous studies of other agents, while the baseline KCCQ score reflects a population with meaningful symptom burden. Combined with the substantial over enrollment and representation of both major HCM subtypes, we believe SONATA-HCM is well positioned to evaluate sotagliflozin across the broad spectrum of symptomatic HCM patients.”

SONATA-HCM is the only ongoing Phase 3 study in both nHCM and oHCM and is the largest Phase 3 study including both nHCM and oHCM to date. Topline results are anticipated in the first quarter of 2027.

About Sotagliflozin
Discovered using Lexicon’s unique approach to gene science, sotagliflozin is an oral inhibitor of two proteins responsible for glucose regulation known as sodium-glucose cotransporter types 2 and 1 (SGLT2 and SGLT1). SGLT2 is responsible for glucose and sodium reabsorption by the kidney and SGLT1 is responsible for glucose and sodium absorption in the gastrointestinal tract and the heart. Sotagliflozin has been studied in multiple patient populations encompassing heart failure, diabetes, and chronic kidney disease in clinical studies involving approximately 20,000 patients. Sotagliflozin is also currently under investigation for hypertrophic cardiomyopathy (HCM).

About Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a biopharmaceutical company pursuing novel medicines for patients with serious cardiometabolic diseases. Building on a proven legacy in genetic target discovery, Lexicon is advancing a clinical pipeline in areas of significant and often underserved need, with programs in hypertrophic cardiomyopathy (HCM), type 1 diabetes (T1D), obesity and other related metabolic conditions. Lexicon is committed to developing differentiated therapies that can be integrated broadly into clinical practice, with the goal of expanding treatment options for patients. Its capabilities extend from early-stage target discovery through clinical development and commercialization, strategically paired with high-impact collaborations to maximize the global reach of its medicines.

For additional information, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains “forward-looking statements,” including statements relating to the research, development and therapeutic and commercial potential of sotagliflozin in hypertrophic cardiomyopathy. In addition, this press release may also contain forward-looking statements relating to Lexicon’s financial position and long-term outlook on its business, including the commercialization of its approved products and the clinical development of, regulatory filings for, and potential therapeutic and commercial potential of its other drug candidates. In addition, this press release also contains forward looking statements relating to Lexicon’s growth and future operating results, discovery, development and commercialization of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management’s current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including Lexicon’s ability to meet its capital requirements, successfully commercialize its approved products, successfully conduct preclinical and clinical development and obtain necessary regulatory approvals of its other drug candidates on its anticipated timelines, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its approved products and other drug candidates. Any of these risks, uncertainties and other factors may cause Lexicon’s actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under “Risk Factors” in Lexicon’s annual report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

Posted in UncategorizedTagged GlobeNewswire

Founder Group Limited Regains Compliance with Nasdaq’s Minimum Publicly Held Shares Requirement

Posted on October 23, 2026 by Ravi Shankar

SELANGOR, Malaysia, Oct. 23, 2026 (GLOBE NEWSWIRE) — Founder Group Limited (NASDAQ: FGL) (“FGL” or the “Company”) today announced that it received a letter dated October 19, 2026 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq’s minimum publicly held shares requirement under Listing Rule 5550(a)(4) (the “Listing Rule”).

Nasdaq previously notified the Company on September 16, 2026 that it did not comply with the minimum 500,000 publicly held shares requirement for The Nasdaq Capital Market under the Listing Rule. Based on the Company’s confirmation dated October 9, 2026 that it has 541,791 publicly held shares, Nasdaq determined that the Company complies with the Listing Rule and that this matter is now closed.

About Founder Group Limited

Founder Group Limited is a pure-play, end-to-end EPCC solutions provider for solar PV facilities in Malaysia. The company’s primary focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. The company’s mission is to provide customers with innovative solar installation services, promote eco-friendly resources and achieve carbon neutrality.

For more information on the Company, please visit https://www.founderenergy.com.my/.

Safe Harbor Statement

This press release contains forward-looking statements that reflect our current expectations and views of future events. Known and unknown risks, uncertainties and other factors, including those listed under “Risk Factors” in the Company’s filings with the U.S. Securities and Exchange Commission, may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements involve various risks and uncertainties. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. We qualify all of our forward-looking statements by these cautionary statements.

Contact Information

For media queries, please contact:

Founder Group Limited
info@founderenergy.com.my

Posted in UncategorizedTagged GlobeNewswire

House of Doge Accelerates Expansion Into Tokenized Yield Vaults With Acquisition from McQueen Labs, Targeting Multibillion-Dollar Tokenized Asset Market

Posted on October 23, 2026 by Ravi Shankar

Acquisition accelerates House of Doge’s expansion into tokenized alternative investments and on-chain yield, company investigating financing alternatives, plans to seek stockholder approval for a reverse split of its common stock.

MIAMI, Oct. 23, 2026 (GLOBE NEWSWIRE) — House of Doge Inc. (NASDAQ: HODO) today announced an agreement to acquire the tokenization platform and credit assets of McQueen Labs Inc., marking a major push into the $51 billion tokenized real-world asset market and accelerating plans to introduce tokenized yield vaults that put real-world credit assets to work on blockchain rails.

The acquisition marks the beginning of a new chapter for House of Doge, as the company sharpens its focus on tokenized alternative investments and on-chain yield. A forthcoming corporate rebrand is also part of the company’s plans, with additional strategic announcements expected in the months ahead. As part of the announced transaction, Mr. Curt Hopkins, CEO of McQueen Labs, will be appointed interim CEO and CFO of House of Doge, Inc. Following the closing, it is anticipated that Mr. Hopkins’s CEO appointment will be made permanent, while a search will be conducted for a CFO.

Supporting this strategic expansion, House of Doge is examining financing alternatives to pursue growth opportunities, accelerate its tokenization strategy, and support its broader ambitions in digital finance. In addition, the company expects to file a proxy statement in the near future in connection with its annual meeting of stockholders, which will include a proposal to approve the reverse split of its common stock.

A $51 Billion Market Opportunity

Tokenization is transforming how real-world assets are owned, traded, and used in financial markets. According to Bernstein Research data reported by Cointelegraph in May 2026, the tokenized real-world asset market reached approximately $51 billion, growing 42% year to date, with private credit accounting for roughly 44% of the market.

House of Doge aims to capitalize on this momentum by moving beyond tokenized ownership into tokenized yield vaults, designed to unlock new opportunities for generating yield from real-world assets.

“This acquisition marks an important step toward the future we’re building,” said Sarosh Mistry, Chairman of House of Doge. “McQueen Labs brings the technology and assets to accelerate our vision for tokenized yield vaults and alternative investments. With a new corporate identity, a sharper strategic focus, and more developments ahead, we’re laying the groundwork for the next phase of our growth.”

“Investors globally are seeking higher yields, yet traditional markets often fail to adequately compensate them for liquidity, credit, and duration risk,” said Curt Hopkins, CEO of McQueen Labs and newly appointed interim CEO and CFO of House of Doge Inc. “Tokenized private credit and blockchain-based lending secured by these assets represent an enormous market opportunity. At McQueen Labs, we’ve built a leading tokenization platform focused on high-demand alternative assets historically inaccessible to most investors. Joining forces with House of Doge will accelerate our growth, expand distribution, and open the door to new asset classes.”

Tokenized Yield Vaults: Putting Real-World Assets to Work

At the center of House of Doge’s expansion are tokenized yield vaults, structured blockchain-based products designed to accept tokenized credit assets as collateral and create new opportunities to access yield from income-producing alternative investments.

By combining real-world credit assets with blockchain-based financial infrastructure, House of Doge aims to move beyond simply tokenizing ownership, creating products that enable tokenized assets to be used within a broader on-chain financial ecosystem.

McQueen Labs, operator of MCQ Markets, developed its tokenization platform to enable fractional ownership of high-value collector cars, private credit and future alternative asset classes. House of Doge plans to leverage this infrastructure and the acquired credit assets to accelerate the development of its vault offerings and expand into tokenized credit, sports investments and yield-oriented products.

The acquisition complements House of Doge’s existing strategic interests in professional sports franchises and advances its focus on building a platform for tokenized alternative investments.

Transaction terms and the anticipated launch timeline for the yield vaults have not yet been disclosed. Further details regarding the corporate rebrand, share consolidation, and additional strategic initiatives will be announced separately.

Leadership Transition

House of Doge also announced that Marco Margiotta, its Chief Executive Officer, and Charles Park, its Chief Financial Officer, have resigned from their positions, effective October 22, 2026. House of Doge thanks Mr. Margiotta and Mr. Parks for their contributions to the company.

Effective immediately, Curt Hopkins, Chief Executive Officer of McQueen Labs, has been appointed to serve as Interim Chief Executive Officer and Interim Chief Financial Officer of House of Doge.

About House of Doge

House of Doge Inc. (NASDAQ: HODO) is building the next generation of alternative investing, combining blockchain innovation with real-world assets to unlock new opportunities for investors. With a growing portfolio spanning tokenized investments, digital finance, and strategic interests in professional sports franchises, the company is focused on transforming how alternative assets are accessed, owned, and monetized.

About McQueen Labs

McQueen Labs Inc. is pioneering tokenized real-world assets with an integrated platform unlocking access, liquidity, and investment opportunities across traditionally exclusive asset classes. Through its flagship platform, MCQ Markets, the company has launched SEC-qualified fractional investment offerings in high-value collector cars, achieving multiple successful exits with double-digit investor returns. Its capabilities span private credit, tokenized lending, and alternative assets, combining investment expertise with blockchain technology to advance the next generation of capital markets.

STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Information and statements contained in this news release that are not historical facts constitute “forward-looking information” and “forward-looking statements” involving risks and uncertainties relating to House of Doge’s current expectations, intentions, plans and beliefs. Forward-looking information can often be identified by words such as “anticipate,” “believe,” “expect,” “goal,” “plan,” “target,” “intend,” “estimate,” “could,” “should,” “may” and “will,” or the negative of these terms or similar expressions suggesting future outcomes, events or performance.

Examples of forward-looking information in this news release include, without limitation: completing the proposed acquisition of McQueen Labs’ tokenization platform and credit assets and satisfying applicable closing conditions; integrating and utilizing the acquired platform and assets; realizing the anticipated benefits of the acquisition, including accelerated growth, expanded distribution and access to additional asset classes; developing and introducing tokenized yield vaults that accept tokenized credit assets as collateral; creating opportunities to access yield from income-producing alternative investments; expanding into tokenized credit, sports investments and yield-oriented products; building a broader platform for tokenized alternative investments and on-chain financial activity; establishing and utilizing a proposed $100 million at-the-market equity offering program to support growth and strategic initiatives; completing a corporate rebrand and share consolidation; and announcing further details regarding these initiatives and the anticipated launch timeline for the yield vaults. Forward-looking information also includes expectations regarding the growth and potential of the tokenized real-world asset market and the Company’s ability to capitalize on those opportunities.

These statements are based on assumptions that may change or prove incorrect, including assumptions regarding the completion of the proposed acquisition, the successful integration and performance of the acquired platform and credit assets, the availability of financing on acceptable terms, investor demand, market conditions, applicable regulatory requirements and approvals, and the Company’s ability to develop and launch its planned products and execute its strategy.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied. These include the risk that the proposed acquisition may not close on the anticipated terms or at all; integration and execution challenges; adverse market or regulatory developments; credit defaults, collateral valuation changes and liquidity constraints; technology, blockchain, smart contract and cybersecurity risks; an inability to establish or raise capital through the proposed at-the-market equity offering program; dilution resulting from equity issuances; delays in obtaining necessary approvals or developing and launching products; and the possibility that the corporate rebrand, share consolidation or other planned initiatives may be delayed or not completed.

Readers should not place undue reliance on forward-looking information. Actual results may differ materially from expectations, and there can be no assurance that the proposed acquisition, planned products, financing initiatives or other strategic objectives will be completed or achieve their intended benefits, or that any yield-oriented products will generate positive returns. Forward-looking information is provided as of the date of this news release. House of Doge undertakes no obligation to publicly update or otherwise revise any forward-looking information, except as required by applicable law.

Media Contacts

press@houseofdoge.com

press@mcqmarkets.com

Posted in UncategorizedTagged GlobeNewswire

Golar releases 2025 Environmental, Social and Governance report

Posted on October 23, 2026 by Ravi Shankar

Golar LNG Limited is pleased to announce the publication of its 2025 Environment, Social and Governance Report.

During 2025, our operating FLNG fleet grew and production increased. Amongst several achievements across the metrics we track, we recorded a record-low level of retainage on the fully utilised Gimi, while Hilli continued to deliver market-leading operational performance. LNG was produced more efficiently with both FLNGs outperforming their already competitively low carbon-intensity targets as a result.

Further details on our performance across our five key focus areas—Health, Safety and Security; Environmental Impact; People and Communities; Innovation and Transition; and Governance and Ethics—are available in our 2025 report on our website here.

FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements (as defined in Section 21E of the Securities Exchange Act of 1934, as amended). All statements, other than statements of historical facts, that address activities and events that will, should, could or may occur in the future are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “expect,” “plan,” “anticipate,” “intend,” “forecast,” “believe,” “estimate,” “predict,” “propose,” “potential,” “continue,” or the negative of these terms and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve many risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Golar LNG undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise, unless required by applicable law.

Hamilton, Bermuda
October 23, 2026
Investor Questions: +44 207 063 7900
Karl Fredrik Staubo – CEO
Eduardo Maranhão – CFO

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Posted in UncategorizedTagged GlobeNewswire

LKQ Corporation Announces Preliminary Third Quarter 2026 Results and Leadership and Operational Actions

Posted on October 23, 2026 by Ravi Shankar

Salvatore A. Abbate appointed President and Chief Executive Officer

Third quarter results reflect significant underperformance in Europe

Alvarez & Marsal retained to advise Company on European operations

Withdraws full-year 2026 guidance

ANTIOCH, Tenn., Oct. 23, 2026 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) today announced preliminary, unaudited results for the third quarter ended September 30, 2026, as well as leadership and operational actions intended to address recent performance and position the Company for improved execution under new leadership.

Preliminary Third Quarter 2026 Results

Based on preliminary unaudited financials for the third quarter, LKQ expects to report the following:

Revenue of $3.32 billion, compared with $3.50 billion in the third quarter of 2025
Parts and services organic revenue decline of 5.4%
Net loss¹ of $16 million to $32 million, including $111 million of non-cash impairment charges, compared with net income¹ of $178 million in the third quarter of 2025
Diluted loss per share¹ of $0.06 to $0.12, including $0.42 per share of non-cash impairment charges, compared with diluted EPS of $0.69 in the third quarter of 2025
Adjusted diluted EPS^1,2 of $0.47 to $0.53, compared with $0.84 in the third quarter of 2025
Europe parts and services organic revenue decline of 9.8%; and segment EBITDA margin of 4.1% to 5.1%, compared with 10.0% in the third quarter of 2025

The third quarter results primarily reflect underperformance in the Europe segment, including operational disruptions associated with the ERP implementation in Germany and volume declines in the United Kingdom and Benelux. While Specialty was modestly below expectations, the shortfall was more limited, and North America performed in line with the Company’s expectations despite softer market conditions.

The Company will report full third quarter results on October 29, 2026, and will hold a conference call at that time.

Leadership Changes

LKQ today announced the appointment of Salvatore A. Abbate as President and Chief Executive Officer, effective December 15, 2026. He succeeds Justin Jude, who is departing the Company effective today. Until Mr. Abbate assumes the role of President and Chief Executive Officer, the Company has established an interim Office of the Chief Executive Officer to provide ongoing leadership continuity, consisting of John Mendel, Chairman of the Board, and Sue Gove, Chair of LKQ’s Audit Committee. The Office of the Chief Executive Officer will work closely with LKQ’s leadership team in overseeing the Company’s operations during the interim period.

(1) References in this release to Net (loss) income and Diluted (loss) earnings per share, and the corresponding adjusted figures, reflect amounts from continuing operations attributable to LKQ stockholders.

(2) Non-GAAP measure. See the table accompanying this release that reconciles the actual or forecasted U.S. GAAP measure to the actual or forecasted adjusted measure, which is non-GAAP.

Also effective today, Andy Hamilton is departing his role as President and Managing Director of LKQ Europe. The Board has engaged Alvarez & Marsal (“A&M”) to advise the Company on its European operations, with an initial focus on improving customer service levels, stabilizing operations and strengthening performance and cost discipline across the region.

“LKQ’s performance, particularly in Europe, has fallen significantly short of the Board’s expectations, and the Board is taking decisive action to address it,” said John Mendel, Chairman of the Board. “We have strong conviction in LKQ’s business and its potential to create significant value for shareholders. Sal is a proven operator with a track record of driving performance in complex distribution businesses, and A&M brings deep experience in operational improvement. Together with LKQ’s talented teams, we are focused on improving execution and delivering improved results for our stakeholders.”

Withdrawal of Full-Year 2026 Guidance

Considering the third quarter results in Europe and the appointment of Mr. Abbate as President and Chief Executive Officer, effective December 15, 2026, LKQ is withdrawing its full-year 2026 guidance, which was most recently updated on July 30, 2026.

Strategic Review Update

In connection with the Board’s ongoing review of strategic alternatives, the Company has taken several actions, including appointing Mr. Abbate as the Company’s next President and Chief Executive Officer, implementing leadership changes within its European operations, and retaining A&M to advise the Company with respect to its European operations. The Company will provide additional updates regarding the strategic alternatives process as appropriate.

About LKQ Corporation

LKQ Corporation (www.lkqcorp.com) is a leading provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles. LKQ has operations in North America, Europe and Taiwan. LKQ offers its customers a broad range of OE recycled and aftermarket parts, replacement systems, components, equipment, and services to repair and accessorize automobiles, trucks, and recreational and performance vehicles.

The following unaudited table reconciles Net (Loss) Income and Diluted (Loss) Earnings per Share to Adjusted Net Income and Adjusted Diluted (Loss) Earnings per Share, respectively:

	Three Months Ended September 30,
	2026							2025
	*Preliminary*
(In millions, except per share data)		Low			High
Net (loss) income	$	(35	)	$	(19	)	$	180
Less: net (loss) income attributable to continuing noncontrolling interest		(1	)		(1	)		—
Net (loss) income attributable to LKQ stockholders		(34	)		(18	)		180
Less: net (loss) income from discontinued operations		(2	)		(2	)		2
Net (loss) income from continuing operations attributable to LKQ stockholders		(32	)		(16	)		178
Adjustments:
Amortization of acquired intangibles		34			34			37
Restructuring and transaction related expenses		24			24			14
Impairment of goodwill		88			88			—
Impairment of net assets held for sale		23			23			—
Direct impacts of Ukraine/Russia conflict		4			4			—
Excess tax deficiency from stock-based payments		1			1			—
Tax effect of adjustments		(23	)		(23	)		(13	)
Adjusted net income	$	119		$	135		$	216

Weighted average diluted common shares o/s		252.9			252.9			257.3

Diluted (loss) earnings per share:
Reported	$	(0.12	)	$	(0.06	)	$	0.69
Adjusted	$	0.47		$	0.53		$	0.84

We have presented Adjusted Net Income and Adjusted Diluted Earnings per Share as we believe these measures are useful for evaluating the core operating performance of our continuing business across reporting periods and in analyzing our historical operating results. We define Adjusted Net Income and Adjusted Diluted Earnings per Share as Net Income and Loss and Diluted Earnings (Loss) per Share adjusted to eliminate the impact of net income and loss attributable to noncontrolling interest, income and loss from discontinued operations, restructuring and transaction related expenses, amortization expense related to all acquired intangible assets, gains and losses on debt extinguishment, changes in fair value of contingent consideration liabilities, other gains and losses related to acquisitions, equity method investments, or divestitures, impairment charges, direct impacts of the Ukraine/Russia conflict, excess tax benefits and deficiencies from stock-based payments and any tax effect of these adjustments. The tax effect of these adjustments is calculated using the effective tax rate for the applicable period or for certain discrete items the specific tax expense or benefit for the adjustment. These financial measures are used by management in its decision making and overall evaluation of our operating performance and are included in the metrics used to determine incentive compensation for our senior management. Adjusted Net Income and Adjusted Diluted Earnings per Share should not be construed as alternatives to Net Income and Loss or Diluted Earnings (Loss) per Share as determined in accordance with accounting principles generally accepted in the United States. In addition, not all companies that report measures similar to Adjusted Net Income and Adjusted Diluted Earnings per Share calculate such measures in the same manner as we do and, accordingly, our calculations are not necessarily comparable to similarly-named measures of other companies and may not be appropriate measures for performance relative to other companies.

Forward-Looking Statements

Statements and information in this press release that are not historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are made pursuant to the “safe harbor” provisions of such Act.

Forward-looking statements include, but are not limited to, statements regarding our outlook, expectations, beliefs, hopes, intentions and strategies. These statements are subject to a number of risks, uncertainties, assumptions and other factors including those identified in our filings with the SEC. All forward-looking statements are based on information available to us at the time the statements are made. We undertake no obligation to update any forward- looking statements, whether as a result of new information, future events or otherwise, except as required by law.

You should not place undue reliance on our forward-looking statements. Actual events or results may differ materially from those expressed or implied in the forward-looking statements. The risks, uncertainties, assumptions and other factors that could cause actual events or results to differ from the events or results predicted or implied by our forward- looking statements include the factors discussed in our filings with the SEC, and other factors discussed in our filings with the SEC, including those disclosed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our subsequent Quarterly Reports on Form 10-Q. These reports are available at the Investor Relations section on our website (www.lkqcorp.com) and on the SEC’s website (www.sec.gov).

Preliminary Financial Information

The preliminary third quarter financial highlights presented in this press release are derived from our internal records and based on the most recent current information available to management, are subject to the closing and finalization of financial and accounting procedures for the period (which have yet to be performed) and should not be viewed as a substitute for our full financial statements prepared in accordance with GAAP. Our normal reporting processes with respect to the preliminary estimated financial data provided in this press release have not been fully completed. As a result, these preliminary estimated results may differ from the actual results that will be reflected in our unaudited condensed consolidated financial statements for the third quarter of 2026 when they are completed. While we believe that these estimates are based on reasonable assumptions, our actual results may vary, and such variations may be material.

Investor Contact

Joseph P. Boutross LKQ Corporation
Vice President, Investor Relations
(312) 621-2793
jpboutross@lkqcorp.com

Media Contact

Whit Clay
Longacre Square Partners
lkq@longacresquare.com

Posted in UncategorizedTagged GlobeNewswire

Mineros Proposes Approximately US$58 Million Special Dividend, Equivalent to US$0.20 Per Share, and Calls Special Meeting of Shareholders

Posted on October 23, 2026 by Ravi Shankar

MEDELLÍN, Colombia, Oct. 23, 2026 (GLOBE NEWSWIRE) — Mineros S.A. (TSX: MSA; BVC: MINEROS; OTCQX: MNSAF) (“Mineros” or the “Company”) announces that its Board of Directors has called an extraordinary meeting of shareholders (the “Meeting”). The Meeting will be held at 10:00 a.m. (Colombia time) on November 24, 2026, in the Salón Gran Real of the Hotel Marriott, Calle 1a Sur #43a-83, Medellín, Antioquia, Colombia.

The matters to be voted on or addressed at the Meeting are as follows:

1. Verification of quorum and introduction to the Meeting.
2. Approval of the Meeting agenda.
3. Appointment of the commission for the scrutiny, review and approval of the minutes of the Meeting.
4. Approval of the release of occasional reserves and distribution of the amount released to shareholders as an extraordinary dividend.

Proposed Extraordinary Dividend

At the Meeting, shareholders will be asked to approve the release of a portion of the Company’s occasional reserves, constituted out of profits of fiscal years ended on or before December 31, 2025, and the distribution of the released amount as a one-time extraordinary cash dividend of US$0.20 per common share (the “Extraordinary Dividend”).

If approved, the Extraordinary Dividend will be payable in a single instalment on December 4, 2026, to shareholders of record on December 1, 2026. It is in addition to, and does not affect, the ordinary dividend of US$0.10 per share approved on March 27, 2026. The Board recommends that shareholders vote FOR the resolution.

Dividends paid to shareholders holding through the Canadian system will be subject to a 20% Colombian withholding tax. Eligible shareholders may claim any excess withholding through the procedure described in the Management Information Circular dated October 15, 2026 (the “Circular”).

Meeting Materials and Voting

The record date for shareholders in the Canadian market is October 15, 2026. To be valid, proxies and voting instruction forms must be received by TSX Trust Company no later than 10:00 a.m. (Colombia time) on November 20, 2026.

The Company is using notice-and-access. The Circular and related materials are available on SEDAR+ at www.sedarplus.com, at https://docs.tsxtrust.com/MSA2026, and on the Company’s website at www.mineros.com.co. A live listen-only webcast of the Meeting will be available on the Company’s website.

About Mineros S.A.
Mineros is a leading Latin American gold producer headquartered in Medellín, Colombia. The Company benefits from a diversified asset portfolio, encompassing operating mines in Colombia and Nicaragua, alongside a pipeline of development and exploration projects located throughout the region, including the Porvenir development asset in Nicaragua, the La Pepa Project in Chile and the Tolima Project in Colombia.

With an operating history spanning over 50 years, Mineros is defined by a commitment to safety, sustainability, and disciplined capital allocation. Its common shares are listed on the Toronto Stock Exchange (MSA) and the Colombia Stock Exchange (MINEROS), and trade on the OTCQX® Best Market under the symbol MNSAF.

For Further Information
Ann Wilkinson | Vice President, Investor Relations
+1 (647) 496-3011 | Ann.Wilkinson@Mineros.com.co

Juan Camilo Obando | Director, Investor Relations
(+57) 604 266 5757 | Juan.Obando@Mineros.com.co

Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable Canadian securities laws, including statements with respect to the approval, declaration, timing, amount and payment of the Extraordinary Dividend, the amount of occasional reserves available for distribution, the expected tax treatment of the Extraordinary Dividend. Forward-looking information is based upon estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this news release including, without limitation, assumptions about: the approval of the Extraordinary Dividend by the General Shareholders Assembly; the Company’s financial condition, liquidity and cash flows; the absence of restrictions on the payment of dividends under the Company’s financing arrangements; legal, regulatory and tax stability in Colombia and Canada; and the number of common shares outstanding on the record date. While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, regulatory, competitive and other risks and uncertainties, contingencies and other factors that could cause actual actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking information. Forward-looking information involves known and unknown risks, uncertainties and other factors, and does not guarantee future performance. Risks and uncertainties that may cause actual results or developments to be materially different from those expressed in forward-looking information include, without limitation: the General Shareholders Assembly may not approve the Extraordinary Dividend, or may approve it with variations; laws, regulations and tax rates may change; and the Company’s financing arrangements may restrict the payment of dividends. This list is not exhaustive. There can be no assurance that forward-looking information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Forward-looking information contained herein is made as of the date of this news release. The Company disclaims any obligation to update or revise any forward-looking information, except as required by applicable securities laws.

Posted in UncategorizedTagged GlobeNewswire